ENZC (Enzolytics) Float Percentage Of Total Shares Outstanding: 100.00% (As of Jul. 02, 2026)


What is Enzolytics Float Percentage Of Total Shares Outstanding?

Enzolytics ENZC Float Percentage Of Total Shares Outstanding is 100.00% as of Jul. 02, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Enzolytics's float shares is 4,831.04 Mil. Enzolytics's total shares outstanding is 4,831.06 Mil. Enzolytics's float percentage of total shares outstanding is 100.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Enzolytics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Enzolytics's Institutional Ownership is 0.06%.

Enzolytics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Enzolytics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=4,831.04/4,831.06
=100.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 100.00% mean?
Enzolytics (ENZC) has a Float Percentage Of Total Shares Outstanding of 100.00% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Enzolytics and its competitors.
Is Enzolytics' Float Percentage Of Total Shares Outstanding too high?
Enzolytics' current Float Percentage Of Total Shares Outstanding is 100.00%.
How does Enzolytics' Float Percentage Of Total Shares Outstanding compare to competitors?
Enzolytics' Float Percentage Of Total Shares Outstanding of 100.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Enzolytics and its competitors. Enzolytics's current Float Percentage Of Total Shares Outstanding is 100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Float Percentage Of Total Shares Outstanding of 100.00%. The current Float Percentage Of Total Shares Outstanding is 100.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Enzolytics (ENZC), the current Float Percentage Of Total Shares Outstanding is 100.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.